Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Abstract Background Continuous use of glucocorticoids (GCs) has become the primary cause of secondary osteoporosis. Bisphosphonate drugs were given priority over denosumab and teriparatide in the 2017 American College of Rheumatology (ACR) guidelines but have a series of shortcomings. This study aim...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2023-06-01
|
| Serie: | Journal of Orthopaedic Surgery and Research |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13018-023-03920-4 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|